Urakami T - Search Results

1

Pharmacologic treatment strategies in children with type 2 diabetes mellitus.

Urakami T, Kuwabara R, Habu M, Yoshida A, Okuno M, Suzuki J, Takahashi S, Mugishima H. Urakami T, et al. Clin Pediatr Endocrinol. 2013 Jan;22(1):1-8. doi: 10.1292/cpe.22.. Epub 2013 Feb 7. Clin Pediatr Endocrinol. 2013. PMID: 23966754 Free PMC article.

2

A questionnaire survey on the use of quick-acting insulin analog in Japanese children and adolescents with type 1 diabetes.

Urakami T, Kawamura T, Sugihara S, Miyamoto S, Amemiya S, Sasaki N, Matsuura N; Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes. Urakami T, et al. Pediatr Int. 2004 Jun;46(3):285-90. doi: 10.1111/j.1442-200x.2004.01891.x. Pediatr Int. 2004. PMID: 15151544

3

Acute lymphoblastic leukemia in a patient with Prader-Willi syndrome under growth hormone therapy.

Kato M, Mugishima H, Chin M, Urakami T, Harada K. Kato M, et al. Among authors: urakami t. Pediatr Int. 2005 Jun;47(3):336-7. doi: 10.1111/j.1442-200x.2005.02068.x. Pediatr Int. 2005. PMID: 15910463 No abstract available.

4

Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus.

Urakami T, Morimoto S, Owada M, Harada K. Urakami T, et al. Pediatr Int. 2005 Aug;47(4):430-3. doi: 10.1111/j.1442-200x.2005.02075.x. Pediatr Int. 2005. PMID: 16091082

5

Production of pyrroloquinoline quinone by using methanol-utilizing bacteria.

Urakami T, Yashima K, Kobayashi H, Yoshida A, Ito-Yoshida C. Urakami T, et al. Appl Environ Microbiol. 1992 Dec;58(12):3970-6. doi: 10.1128/aem.58.12.3970-3976.1992. Appl Environ Microbiol. 1992. PMID: 16348825 Free PMC article.

6

How should we treat type 2 diabetes in youth?

Urakami T. Urakami T. Pediatr Endocrinol Rev. 2005 Sep;3(1):33-9. Pediatr Endocrinol Rev. 2005. PMID: 16369211 Review.

7

Usefulness of the long-acting insulin analogue glargine in basal-bolus therapy for Japanese children and adolescents with type 1 diabetes mellitus.

Urakami T, Morimoto S, Kubota S, Funaki S, Harada K. Urakami T, et al. J Pediatr Endocrinol Metab. 2007 Jul;20(7):807-15. doi: 10.1515/jpem.2007.20.7.807. J Pediatr Endocrinol Metab. 2007. PMID: 17849743

8

Incidence of children with slowly progressive form of type 1 diabetes detected by the urine glucose screening at schools in the Tokyo Metropolitan Area.

Urakami T, Suzuki J, Yoshida A, Saito H, Mugishima H. Urakami T, et al. Diabetes Res Clin Pract. 2008 Jun;80(3):473-6. doi: 10.1016/j.diabres.2008.01.029. Epub 2008 Mar 21. Diabetes Res Clin Pract. 2008. PMID: 18359120

9

Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes.

Urakami T, Yoshida A, Suzuki J, Saito H, Wada M, Takahashi S, Mugishima H. Urakami T, et al. Diabetes Res Clin Pract. 2009 Jan;83(1):89-93. doi: 10.1016/j.diabres.2008.09.050. Epub 2008 Nov 18. Diabetes Res Clin Pract. 2009. PMID: 19019475

10

Autoimmune characteristics in Japanese children diagnosed with type 1 diabetes before 5 years of age.

Urakami T, Suzuki J, Yoshida A, Saito H, Wada M, Takahashi S, Mugishima H. Urakami T, et al. Pediatr Int. 2009 Aug;51(4):460-3. doi: 10.1111/j.1442-200X.2008.02758.x. Epub 2008 Nov 26. Pediatr Int. 2009. PMID: 19400823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters